229 related articles for article (PubMed ID: 23281213)
1. Characterization of a psoriatic skin model produced with involved or uninvolved cells.
Jean J; Leroy M; Duque-Fernandez A; Bernard G; Soucy J; Pouliot R
J Tissue Eng Regen Med; 2015 Jul; 9(7):789-98. PubMed ID: 23281213
[TBL] [Abstract][Full Text] [Related]
2. Physical characterization of the stratum corneum of an in vitro psoriatic skin model by ATR-FTIR and Raman spectroscopies.
Bernard G; Auger M; Soucy J; Pouliot R
Biochim Biophys Acta; 2007 Sep; 1770(9):1317-23. PubMed ID: 17659842
[TBL] [Abstract][Full Text] [Related]
3. Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model.
Jean J; Soucy J; Pouliot R
Tissue Eng Part A; 2011 Jul; 17(13-14):1859-68. PubMed ID: 21417679
[TBL] [Abstract][Full Text] [Related]
4. Development of an in vitro psoriatic skin model by tissue engineering.
Jean J; Lapointe M; Soucy J; Pouliot R
J Dermatol Sci; 2009 Jan; 53(1):19-25. PubMed ID: 18783923
[TBL] [Abstract][Full Text] [Related]
5. Is the stratum corneum of uninvolved psoriatic skin abnormal?
King CS; Nicholls S; Barton S; Marks R
Acta Derm Venereol Suppl (Stockh); 1979; 59(85):95-100. PubMed ID: 294103
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural localization of calcium in psoriatic and normal human epidermis.
Menon GK; Elias PM
Arch Dermatol; 1991 Jan; 127(1):57-63. PubMed ID: 1986708
[TBL] [Abstract][Full Text] [Related]
7. Defective barrier function accompanied by structural changes of psoriatic stratum corneum.
Takahashi H; Tsuji H; Minami-Hori M; Miyauchi Y; Iizuka H
J Dermatol; 2014 Feb; 41(2):144-8. PubMed ID: 24471458
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
Lizzul PF; Aphale A; Malaviya R; Sun Y; Masud S; Dombrovskiy V; Gottlieb AB
J Invest Dermatol; 2005 Jun; 124(6):1275-83. PubMed ID: 15955104
[TBL] [Abstract][Full Text] [Related]
9. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
[TBL] [Abstract][Full Text] [Related]
10. Abnormal distribution of epidermal protein antigens in psoriatic epidermis.
Watanabe S; Wagatsuma K; Ichikawa E; Takahashi H
J Dermatol; 1991 Mar; 18(3):143-51. PubMed ID: 1715894
[TBL] [Abstract][Full Text] [Related]
11. Epinephrine-induced cyclic AMP accumulation in the psoriatic epidermis.
Iizuka H; Umeda K; Koizumi H; Aoyagi T; Miura Y
Acta Derm Venereol; 1981; 61(5):391-5. PubMed ID: 6172926
[TBL] [Abstract][Full Text] [Related]
12. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
Abe J; Kondo S; Nishii Y; Kuroki T
J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
[TBL] [Abstract][Full Text] [Related]
13. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
14. A Tissue-Engineered Human Psoriatic Skin Model to Investigate the Implication of cAMP in Psoriasis: Differential Impacts of Cholera Toxin and Isoproterenol on cAMP Levels of the Epidermis.
Simard M; Morin S; Rioux G; Séguin R; Loing E; Pouliot R
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717879
[TBL] [Abstract][Full Text] [Related]
15. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
Fisher GJ; Talwar HS; Baldassare JJ; Henderson PA; Voorhees JJ
J Invest Dermatol; 1990 Oct; 95(4):428-35. PubMed ID: 2170539
[TBL] [Abstract][Full Text] [Related]
16. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin.
Gerritsen MJ; Elbers ME; de Jong EM; van de Kerkhof PC
J Dermatol Sci; 1997 Mar; 14(3):179-88. PubMed ID: 9138475
[TBL] [Abstract][Full Text] [Related]
18. Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo.
Wiley HE; Weinstein GD
J Invest Dermatol; 1979 Dec; 73(6):545-7. PubMed ID: 512406
[TBL] [Abstract][Full Text] [Related]
19. [Prostaglandin biosynthesis in psoriatic epidermis (author's transl)].
Michel B; Chantreuil J; Guilhou JJ; Crastes de Paulet A; Meynadier J
Ann Dermatol Venereol; 1980; 107(10):889-93. PubMed ID: 7015965
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of a chemokinetic glycoprotein in psoriatic skin.
Rajaraman S; Schmalsteig FC; Brysk MM; Hendrick SJ; Solomon AR
J Clin Lab Immunol; 1987 May; 23(1):39-43. PubMed ID: 3302266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
